Iridex Corp revenue
Iridex Corp's revenue was $52.7m in fiscal 2025, up 8.2% on the year before. Since fiscal 2009 ($31.0m) it has grown at a compound 3.4% a year. Over the last twelve months it was $51.6m.
Revenue history
| Fiscal year | 2009Jan 2010 | 2010Jan 2011 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Jan 2015 | 2015Jan 2016 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Jan 2021 | 2021Jan 2022 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Jan 2026 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31 | 32 | 33 | 34 | 38 | 43 | 42 | 46 | 42 | 43 | 43 | 36 | 54 | 57 | 52 | 49 | 53 | 52 |
| Growth on the year before | — | +4.1% | +2.6% | +2.1% | +13.0% | +11.9% | −2.5% | +10.5% | −9.9% | +2.4% | +2.0% | −16.3% | +48.3% | +5.7% | −9.0% | −6.2% | +8.2% | — |
| Gross profit | 15 | 16 | 16 | 16 | 19 | 21 | 20 | 21 | 16 | 17 | 18 | 16 | 23 | 25 | 22 | 20 | 19 | 19 |
| Gross margin | 49.8% | 50.1% | 49.1% | 48.3% | 48.6% | 50.0% | 47.8% | 45.1% | 37.3% | 41.0% | 41.3% | 42.8% | 42.4% | 44.5% | 42.0% | 40.1% | 36.5% | 35.9% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Retina | $30.3M | 57.5% | ▲ 8.8% |
| Cyclo G Six | $13.8M | 26.3% | ▲ 9.0% |
| Other | $8.6M | 16.2% | ▲ 5.0% |
| Services | $1,300 | 0.0% | ▼ 7.1% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $23.2M | 44.1% | ▲ 2.3% |
| Europe Middle East and Africa | $14.4M | 27.3% | ▲ 21.7% |
| Asia Pacific | $13M | 24.6% | ▲ 8.4% |
| Americas Excluding US | $2.1M | 4.0% | ▼ 3.8% |
From Iridex Corp's 10-K filed April 2, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Iridex Corp | $51.6m | 3.7% | -2.9% |
| Senseonics Holdings, Inc. | $48.5m | 90.6% | 38.0% |
| Apyx Medical Corp | $58.4m | 25.6% | 7.2% |
| Clearpoint Neuro, Inc. | $45.5m | 32.5% | 26.8% |
| Koru Medical Systems, Inc. | $45.1m | 22.4% | 15.3% |
| Trisalus Life Sciences, Inc. | $45.1m | 25.2% | 45.1% |
Compare with peers
- Senseonics Holdings, Inc. revenue
- Apyx Medical Corp revenue
- Clearpoint Neuro, Inc. revenue
- Koru Medical Systems, Inc. revenue
- Trisalus Life Sciences, Inc. revenue
Head to head: IRIX vs SENSAPYX vs IRIXCLPT vs IRIX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies